REFERENCES
- Schroeder H.W., Jr, Zhu Z.B., March R.E., Campbell R.D., Berney S.M., Nedospasov S.A., Turetskaya R.L., Atkinson T.P., Go R.C., Cooper M.D., Volanakis J.E. Susceptibility locus for IgA deficiency and common variable immunodeficiency in HLA-DR3, -DB8, -A1 haplotypes. Mol Med 1998; 4(2)72–86, [CSA]
- Cunningham-Rundles C. Common variable immunodeficiency. Curr. Allergy Asthma Rep. 2001; 1(5)421–429, [CSA]
- WHO Scientific Group. Primary immunodeficiency diseases. Clin. Exp. Immunol. 1995; 99(1)1–24, [CSA]
- Ashman R.F., Schaffer F.M., Kemp J.D., Yokoyama W.M., Zhu Z.B., Cooper M.D., Volanakis J.E. Genetic and immunologic analysis of a family containing five patients with common variable immunodeficiency or selective IgA deficiency. J Clin Immunol 1992; 12(6)406–414, [CSA], [CROSSREF]
- Vorechovsky I., Cullen M., Carrington M., Hammarstrom L., Webster A.D. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J. Immunol. 2000; 164(8)4408–4416, [CSA]
- Burrows P.D., Cooper M.D. IgA deficiency. Adv. Immunol. 1997; 65: 245–276, [CSA]
- Lewkonia R.M., Gairdner D., Doe W.F. IgA deficiency in one of identical twins. Br Med J 1976; 7(1)311–313, [CSA]
- Zuccaro G., Della Bella S., Polizzi B., Vanoli M., Scorza R. Common variable immunodeficiency following Epstein-Barr virus infection. J. Clin. Lab. Immunol. 1997; 49(1)41–45, [CSA]
- Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunologic features of 248 patients. Clin. Immunol. 1999; 92(1)34–48, [CSA], [CROSSREF]
- Cunningham-Rundles C., Siegal F.P., Cunningham-Rundles S., Lieberman P. Incidence of cancer in 98 patients with common variable immunodeficiency. J. Clin. Immunol. 1987; 7(4)294–300, [CSA], [CROSSREF]
- Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli M.U. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84(9)2919–2922, [CSA]
- Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 2002; 16(1)61–64, [CSA], [CROSSREF]
- Fairweather D., Kaya Z., Shellan G.R., Lawson C.M., Rose N. From infection to autoimmunity. J. Autoimmun. 2001; 16(3)341–345, [CSA], [CROSSREF]
- Strassburg C.P., Obermayer-Straub P., Manns M.P. Autoimmunity in liver diseases. Clin. Rev. Allergy Immunol. 2000; 18(2)127–139, [CSA], [CROSSREF]
- Mosley J.W. Is safe always safe? Pooled plasma derivatives and viral hepatitis. Gastroenterology 1996; 110(4)1307–1310, [CSA], [CROSSREF]
- Strassburg C.P., Vogel A., Manns M.P. Autoimmunity and hepatitis C. Autoimmun. Rev. 2003; 2(6)322–331, [CSA], [CROSSREF]
- Mackie F.D., Peakman M., Yun M., Sallie R., Smith H., Davies E.T., Mieli‐Vergani G., Vergani D. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology 1994; 106(6)1672–1675, [CSA]
- Garcia-Buey L., Garcia-Monzon C., Rodriguez S., Borque M.J., Garcia-Sanchez A. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995; 108(6)1770–1777, [CSA], [CROSSREF]
- Fellermann K., Stange E.F. Chronic hepatitis C, Common variable immunodeficiency and autoimmune hemolytic anemia: coincidence by chance or common etiology?. Hepatogastroenterology 2000; 47(35)1422–1424, [CSA]
- Manns M.P., Griffin K.J., Sullivan K.F., Johnson E.F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P450 monooxygenase. J. Clin. Invest. 1991; 88(4)1370–1378, [CSA]
- Donaldson P.T., Doherty D.G., Hayllay K.M., McFarlane I.G., Johnson P.J., Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13(4)701–706, [CSA], [CROSSREF]
- Gow P.J., Mutimer D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transpl. Int. 2002; 15(7)380–383, [CSA], [CROSSREF]
- Vento S., Cainelli F., Renzini C., Concia E. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance. Lancet 1997; 350(9087)1298–1299, [CSA], [CROSSREF]
- Vogt M., Lang T., Frosner G., Klingler C., Send A.F., Zeller A., Wiebecke B., Langer B., Meisner H., Hess J. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N. Engl. J. Med. 1999; 341(12)866–870, [CSA], [CROSSREF]
- Otsubo H., Kaito K., Ogasawara Y., Shimada T., Usui N., Kobayashi M. Successful immunosoppressive therapy with cyclosporine A for posthepatitis B-cell deficiency with activated cytoplasmic interferon-gamma-positive T-lymphocytes. Int. J. Hematol. 2002; 75(3)285–288, [CSA]